147 related articles for article (PubMed ID: 36579468)
21. Peritoneal resident macrophages in mice with MLL-AF9-induced acute myeloid leukemia show an M2-like phenotype.
Chen C; Wang R; Feng W; Yang F; Wang L; Yang X; Ren L; Zheng G
Ann Transl Med; 2021 Feb; 9(3):266. PubMed ID: 33708893
[TBL] [Abstract][Full Text] [Related]
22. Composition and function of the hemopoietic microenvironment in human myeloid leukemia.
Mayani H
Leukemia; 1996 Jun; 10(6):1041-7. PubMed ID: 8667639
[TBL] [Abstract][Full Text] [Related]
23. Characterization of peritoneal leukemia-associated macrophages in Notch1-induced mouse T cell acute lymphoblastic leukemia.
Chen S; Yang X; Feng W; Yang F; Wang R; Chen C; Wang L; Lin Y; Ren Q; Zheng G
Mol Immunol; 2017 Jan; 81():35-41. PubMed ID: 27888718
[TBL] [Abstract][Full Text] [Related]
24. CircKDM4C upregulates P53 by sponging hsa-let-7b-5p to induce ferroptosis in acute myeloid leukemia.
Dong LH; Huang JJ; Zu P; Liu J; Gao X; Du JW; Li YF
Environ Toxicol; 2021 Jul; 36(7):1288-1302. PubMed ID: 33733556
[TBL] [Abstract][Full Text] [Related]
25. Expression and role of fibroblast activation protein α in acute myeloid leukemia.
Mei S; Zhang Y; Yu L; Chen G; Zi F
Oncol Rep; 2021 Feb; 45(2):641-651. PubMed ID: 33416165
[TBL] [Abstract][Full Text] [Related]
26. Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation.
Que Y; Li H; Lin L; Zhu X; Xiao M; Wang Y; Zhu L; Li D
Front Immunol; 2021; 12():653030. PubMed ID: 34093541
[TBL] [Abstract][Full Text] [Related]
27. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
28. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
29. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
[TBL] [Abstract][Full Text] [Related]
30. Small RNA sequencing profiles of mir-181 and mir-221, the most relevant microRNAs in acute myeloid leukemia.
Lee YG; Kim I; Oh S; Shin DY; Koh Y; Lee KW
Korean J Intern Med; 2019 Jan; 34(1):178-183. PubMed ID: 29172404
[TBL] [Abstract][Full Text] [Related]
31. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation.
Moore JA; Mistry JJ; Hellmich C; Horton RH; Wojtowicz EE; Jibril A; Jefferson M; Wileman T; Beraza N; Bowles KM; Rushworth SA
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 34990402
[TBL] [Abstract][Full Text] [Related]
32. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.
Lopes MR; Pereira JK; de Melo Campos P; Machado-Neto JA; Traina F; Saad ST; Favaro P
Sci Rep; 2017 Jan; 7():40707. PubMed ID: 28084439
[TBL] [Abstract][Full Text] [Related]
33. Serial studies of bone marrow-derived fibroblastoid colony-forming cells and granulocyte/macrophage precursor cells in patients with acute leukemia.
Katsuno M; Hirata J; Kaneko S; Nishimura J; Motomura S; Ibayashi H
Acta Haematol; 1986; 76(4):185-91. PubMed ID: 3107305
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
35. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
[TBL] [Abstract][Full Text] [Related]
36. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs.
Moussa Agha D; Rouas R; Najar M; Bouhtit F; Naamane N; Fayyad-Kazan H; Bron D; Meuleman N; Lewalle P; Merimi M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992819
[TBL] [Abstract][Full Text] [Related]
37. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
[TBL] [Abstract][Full Text] [Related]
39. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients.
Fang J; Zhang R; Lin X; Xu Y; Huang K; Saw PE
Hematology; 2023 Dec; 28(1):2219554. PubMed ID: 37288810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
